Vistex Inc articles

When 20th century sci-fi looked to the distant future, did you ever imagine the world would look like it does today? Well, to be fair, we didn’t factor in a global pandemic. And now, the entire wholesale distribution sector has been impacted. While we may not be driving flying cars or holidaying on Mars (yet), our technology is revolutionizing our ability to pivot dynamically. The most successful wholesale distributors right now are the ones who have quickly become scalable in handling

The risk? According to Medicinenet.com, only 5 in 5,000 drugs that enter preclinical testing advance to human trials. And only 1 of these 5 drugs ultimately gets approved for sale, which means the chance for a new drug to make it to market is 1 in 5,000. That’s a lot of R&D investment.

In the next few months, most retail and foodservice CPG (Consumer Packaged Goods) manufacturers like you, will be starting their annual process for 2021 S&OP (Sales & Operations Planning). Even during “ordinary times” this is an arduous process:

• Rolling out volume targets to plan customers
• Defining trade spend budget targets to drive growth through available merchandising conditions
• Launching new items
• Getting

The COVID pandemic has created a shift in our landscape—challenging brands with building and maintaining their brand loyalty—as our idea of business as usual continues to evolve. As in-person events give way to virtual environments, how can you maintain brand loyalty with your customers? In the past, events have been leveraged to create unique experiences, inviting customers to participate in your brand and ideally generate lasting impressions. Our current state of business provid

A gold rush is on to find a vaccine for COVID-19. According to the World Health Association (WHO) in early May, there are more than 100 projects around the world centered on the development of a vaccine for the coronavirus. Eight candidate vaccines are already being tested in people in clinical trials.

Once an effective vaccine (or vaccines) has been identified, it will need to be produced rapidly and on a massive scale—billions of doses. However, estimating exact production cap